1. Brazil’s perspectives on prioritiesand emerging issues for the global health agendaJuliana Vieira Borges Vallini Health Surveillance Secretary Brasília, 27 de outubro…

1. Regulating the pharmaceutical sector: Coping withlow capacity while maintaining regulatory independence Thulani Matsebula1, Jane Goudge1, Lucy Gilson1,2 HEFP working paper…

Slide 1Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies World Bank Training Program Jabulani Nyenwa, MD, MPH, MBA May 2005 Slide 2 Acknowledgements…

Slide 1 1CONFIDENTIAL Medicinal chemistry meets systems biology John Harris, cjh Consultants (Founder and consultant to BioFocus) “Cutting Edge Approaches to Drug Design”…

PowerPoint Presentation Adrenergic Antagonists The adrenergic antagonists (also called blockers or sympatholytic agents) bind to adrenoceptors but do not trigger the usual…

Slide 1 Analgesic clinical trials and their assay sensitivity Robert H. Dworkin, PhD Professor of Anesthesiology, Neurology, Oncology, and Psychiatry Professor, Center for…

Slide 1 Slide 2 Objectives  To differentiate between occupation and profession.  The hallmarks characteristic of profession.  Factors that threatened pharmacy as…

الشريحة 1 Salha Jokhab, Msc 222 PHCL Pharmaceutical Care Concept Objectives To differentiate between occupation and profession. The hallmarks characteristic of profession.…

Drug Research and Development (R&D) Karol Godwin DVM Cost and time to get drug to market? 250 million dollars â 5 years 500 million dollars â 7 years 800 million dollars…